China National Accord Medicines Corp Ltd Capital Reinvestment Ratio
China National Accord Medicines Corp Ltd capital reinvestment ratio. China National Accord Medicines Corp Ltd (000028) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.83 Billion) in capital expenditures (CN¥50.09 Million). See 000028 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of China National Accord Medicines Corp Ltd (1998–2024)
Capital reinvestment ratio of China National Accord Medicines Corp Ltd from 1998 to 2024. This chart tracks China National Accord Medicines Corp Ltd's Capital Reinvestment Ratio across 26 annual periods. See China National Accord Medicines Corp Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
China National Accord Medicines Corp Ltd Capital Reinvestment Ratio by Year (1998–2024)
China National Accord Medicines Corp Ltd capital reinvestment ratio by year from 1998 to 2024. For the full cash flow conversion analysis, see China National Accord Medicines Corp Ltd cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥3.27 Billion | CN¥282.70 Million | ▼ -21.2% |
| 2023 | 0.11x | CN¥2.94 Billion | CN¥322.21 Million | ▼ -12.8% |
| 2022 | 0.13x | CN¥2.56 Billion | CN¥322.19 Million | ▼ -43.8% |
| 2021 | 0.22x | CN¥1.66 Billion | CN¥370.43 Million | ▲ +14.5% |
| 2020 | 0.20x | CN¥1.50 Billion | CN¥293.83 Million | ▲ +59.5% |
| 2019 | 0.12x | CN¥2.00 Billion | CN¥245.17 Million | ▼ -36.6% |
| 2018 | 0.19x | CN¥1.32 Billion | CN¥255.48 Million | ▲ +21.5% |
| 2017 | 0.16x | CN¥1.29 Billion | CN¥204.35 Million | ▼ -11.9% |
| 2016 | 0.18x | CN¥1.47 Billion | CN¥265.89 Million | ▼ -0.6% |
| 2015 | 0.18x | CN¥1.05 Billion | CN¥190.36 Million | ▼ -43.9% |
| 2013 | 0.32x | CN¥465.03 Million | CN¥150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | CN¥323.96 Million | CN¥193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | CN¥227.32 Million | CN¥198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | CN¥428.16 Million | CN¥177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | CN¥270.85 Million | CN¥102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | CN¥246.58 Million | CN¥84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | CN¥87.70 Million | CN¥71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | CN¥181.73 Million | CN¥118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | CN¥148.28 Million | CN¥50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | CN¥130.30 Million | CN¥14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | CN¥81.22 Million | CN¥49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | CN¥28.76 Million | CN¥26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | CN¥71.16 Million | CN¥35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | CN¥8.52 Million | CN¥21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | CN¥22.84 Million | CN¥27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | CN¥5.21 Million | CN¥10.38 Million | — |